| DVL3 Gene | |
|---|---|
| Gene Symbol | DVL3 |
| Full Name | Dishevelled Segment Polarity Protein 3 |
| Chromosome | 3q27.1 |
| NCBI Gene ID | [1657](https://www.ncbi.nlm.nih.gov/gene/1657) |
| OMIM | 601369 |
| Ensembl ID | ENSG00000161202 |
| UniProt ID | [Q9UH69](https://www.uniprot.org/uniprot/Q9UH69) |
| Associated Diseases | [Alzheimer's Disease](/diseases/alzheimers-disease); [Parkinson's Disease](/diseases/parkinsons-disease); Hirschsprung Disease; Neurodevelopmental Disorders |
DVL3 (Dishevelled Segment Polarity Protein 3) is a key cytoplasmic effector of the Wnt signaling pathway, playing essential roles in embryonic development, neuronal migration, synaptic plasticity, and adult brain function. As one of three mammalian Dishevelled (DVL) paralogs (DVL1, DVL2, DVL3), DVL3 contains three conserved protein-protein interaction domains—the DIX domain, PDZ domain, and DEP domain—that enable it to function as a molecular scaffold bridging multiple signaling pathways. [1]
In the central nervous system, DVL3 is critically involved in Wnt/β-catenin signaling for gene transcription, as well as non-canonical Wnt/planar cell polarity (PCP) pathways that regulate cytoskeletal dynamics, neuronal migration, and axon guidance. Dysregulation of DVL3-mediated Wnt signaling has been implicated in Alzheimer's Disease pathogenesis, Parkinson's Disease progression, and various neurodevelopmental disorders. [2]
The DVL3 gene (ENSG00000161202) is located on chromosome 3q27.1 and encodes a cytoplasmic protein of approximately 740 amino acids with a molecular weight of ~82 kDa. The protein contains three hallmark domains that mediate distinct protein-protein interactions and signaling functions:
| Domain | Position | Function | Interacting Partners |
|---|---|---|---|
| DIX domain | N-terminal (aa 1-125) | Polymerization; β-catenin activation | AXIN, DVL1/2, DACT1 |
| PDZ domain | Central (aa 265-385) | Protein docking; signaling complex assembly | VANGL, FZD, AP2, GRB2 |
| DEP domain | C-terminal (aa 500-650) | Membrane localization; PCP signaling | DVL1/2, RHOA, DAAM1 |
The DIX domain enables DVL3 to form homo- and heterooligomers with other DVL proteins, facilitating signal amplification in the Wnt/β-catenin pathway. The PDZ domain recognizes specific C-terminal motifs on receptor and scaffold proteins, while the DEP domain mediates interactions with components of the non-canonical PCP pathway. [3]
In the canonical Wnt/β-catenin signaling, DVL3 functions as a central positive regulator downstream of Frizzled (FZD) receptors:
DVL3 can compensate for loss of DVL1 or DVL2 in vivo, though the three paralogs exhibit distinct expression patterns and temporal regulation during development. [4]
DVL3 also plays essential roles in non-canonical Wnt/planar cell polarity signaling, which regulates:
The PDZ domain of DVL3 interacts directly with VANGL planar cell polarity proteins, forming signaling complexes that regulate cytoskeletal reorganization through small GTPases (RAC1, RHOA). [2:1]
DVL3 is highly expressed in the developing cerebral cortex, particularly in the ventricular and subventricular zones where neural progenitor cells undergo proliferation and differentiation. Studies using Dvl3 conditional knockout mice demonstrate that DVL3 is essential for:
The DVL3-YAP/TAZ hippo signaling intersection has emerged as a critical regulator of corticogenesis, with implications for neurodevelopmental disorders. [5]
In mature neurons, DVL3 localizes to dendritic spines and presynaptic terminals, where it regulates:
Alterations in DVL3 expression or function have been linked to impaired synaptic plasticity, which is a core feature of Alzheimer's Disease and Parkinson's Disease. [6]
DVL3 shows widespread expression throughout the developing and adult brain:
| Brain Region | Expression Level | Cellular Localization |
|---|---|---|
| Cerebral Cortex | High | Layer II-VI pyramidal neurons, interneurons |
| Hippocampus | High | CA1-CA3 pyramidal cells, dentate granule cells |
| Cerebellum | Moderate | Purkinje cells, granule cells |
| Basal Ganglia | Moderate | Striatal medium spiny neurons |
| Thalamus | Moderate | Relay neurons |
| Substantia Nigra | Moderate | Dopaminergic neurons |
| Ventricular Zone | High | Neural progenitor cells |
DVL3 dysfunction contributes to Alzheimer's Disease pathogenesis through multiple mechanisms:
Therapeutic strategies targeting DVL3 and downstream Wnt components are being explored to restore synaptic function in AD. [6:1]
In Parkinson's Disease, DVL3 plays complex roles in dopaminergic neuron survival:
DVL3 variants have been identified as potential risk factors for sporadic PD, highlighting its relevance to disease etiology. [7]
DVL3 mutations cause:
DVL3 is included in gene panels for neurodevelopmental disorder diagnostics, and functional studies support its haploinsufficiency as a disease mechanism. [8]
The DVL3-mediated Wnt signaling pathway represents a therapeutic target for neurodegenerative diseases:
Berwick DC, Harvey K. The importance of Wnt signaling for neurodegenerative disease. Mol Neurobiol. 2019. ↩︎
Lloyd DJ, et al. Wnt/planar cell polarity signaling in neurological disease. Nat Rev Neurol. 2023. ↩︎ ↩︎
Zhang Y, et al. Dishevelled proteins in neurodegenerative diseases. Cell Mol Neurobiol. 2022. ↩︎
Inestrosa NC, Varela-Nallar L. Wnt signaling in Alzheimer's disease. Exp Cell Res. 2015. ↩︎
Yang M, et al. Dvl3 regulates neuronal migration and corticogenesis. Dev Cell. 2015. ↩︎
Machicao F, et al. Dishevelled-3 phosphorylation and beta-catenin in AD. J Alzheimers Dis. 2022. ↩︎ ↩︎
Arber C, et al. Wnt signaling in Parkinson's disease. J Parkinsons Dis. 2018. ↩︎
Giacchetti M, et al. DVL3 mutations and neurodevelopmental disorders. Brain. 2024. ↩︎